ID

5592

Beschrijving

ODM derived from http://clinicaltrials.gov/show/NCT00168051

Link

http://clinicaltrials.gov/show/NCT00168051

Trefwoorden

  1. 05-12-11 05-12-11 -
  2. 13-04-14 13-04-14 - Julian Varghese
  3. 10-08-14 10-08-14 - Martin Dugas
  4. 20-09-21 20-09-21 -
Geüploaded op

10 augustus 2014

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility NCT00168051 Hemophilia A

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years to 64 Years
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI-1
C0001779
Male
Beschrijving

Male gender

Datatype

boolean

Alias
UMLS CUI-1
C0024554
Severe hemophilia A
Beschrijving

Severe hemophilia A

Datatype

boolean

Alias
UMLS CUI-1
C0019069
Previously treated patients with at least 150 exposure days to any Factor VIII product
Beschrijving

Treatment with Factor VIII

Datatype

boolean

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0015506
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Hypersensitivity to any recombinant Factor VIII product
Beschrijving

Hypersensitivity Factor VIII

Datatype

boolean

Alias
UMLS CUI-1
C0020517
UMLS CUI-2
C0015506
History of or current Factor VIII inhibitor
Beschrijving

Factor VIII inhibitor

Datatype

boolean

Alias
UMLS CUI-1
C0368953
Bleeding episode or other reason requiring Factor VIII treatment within 3 days of study
Beschrijving

Bleeding episode

Datatype

boolean

Alias
UMLS CUI-1
C0005779

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years to 64 Years
boolean
C0001779 (UMLS CUI-1)
Male
Item
Male
boolean
C0024554 (UMLS CUI-1)
Hemophilia A
Item
Severe hemophilia A
boolean
C0019069 (UMLS CUI-1)
Treatment with Factor VIII
Item
Previously treated patients with at least 150 exposure days to any Factor VIII product
boolean
C0087111 (UMLS CUI-1)
C0015506 (UMLS CUI-2)
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Hypersensitivity Factor VIII
Item
Hypersensitivity to any recombinant Factor VIII product
boolean
C0020517 (UMLS CUI-1)
C0015506 (UMLS CUI-2)
Factor VIII inhibitor
Item
History of or current Factor VIII inhibitor
boolean
C0368953 (UMLS CUI-1)
Bleeding episode
Item
Bleeding episode or other reason requiring Factor VIII treatment within 3 days of study
boolean
C0005779 (UMLS CUI-1)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial